Prognostic implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy for advanced malignancies: A retrospective cohort study.
作者信息
Molina Gabriel E, Allen Ian M, Hughes Michael S, Zubiri Leyre, Lee Hang, Mooradian Meghan J, Reynolds Kerry L, Dougan Michael, Chen Steven T
机构信息
Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
出版信息
J Am Acad Dermatol. 2020 Mar;82(3):743-746. doi: 10.1016/j.jaad.2019.07.049. Epub 2019 Jul 23.
Abstract
摘要
相似文献
1
Prognostic implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy for advanced malignancies: A retrospective cohort study.免疫检查点抑制疗法治疗晚期恶性肿瘤时并发皮肤和胃肠道毒性的预后意义：一项回顾性队列研究。
J Am Acad Dermatol. 2020 Mar;82(3):743-746. doi: 10.1016/j.jaad.2019.07.049. Epub 2019 Jul 23.
2
Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort.IV期非小细胞肺癌患者中与靶向治疗和免疫治疗相关的皮肤毒性：一项为期14年的队列研究。
J Am Acad Dermatol. 2024 Jul;91(1):172-175. doi: 10.1016/j.jaad.2024.03.029. Epub 2024 Mar 29.
3
[Immunotherapy with immune checkpoint inhibitor and skin toxicity].
Rev Med Suisse. 2020 May 27;16(695):1086-1091.
4
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.免疫检查点抑制剂治疗相关炎症性皮疹：毒性分层的单机构回顾性分析及其对治疗的影响。
J Am Acad Dermatol. 2019 Apr;80(4):990-997. doi: 10.1016/j.jaad.2018.10.062. Epub 2018 Nov 3.
5
Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern.免疫检查点阻断治疗引起的具有间质肉芽肿模式的皮肤毒性。
J Cutan Pathol. 2018 Jul;45(7):504-507. doi: 10.1111/cup.13150. Epub 2018 Apr 23.
6
Eosinophilic colitis due to rifampicin.利福平所致嗜酸性粒细胞性结肠炎
Lancet. 1994 Nov 5;344(8932):1296-7. doi: 10.1016/s0140-6736(94)90782-x.
7
8
Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern.接受免疫检查点阻断治疗患者的皮肤疹：非苔藓样组织学模式的临床病理分析
Am J Surg Pathol. 2017 Oct;41(10):1381-1389. doi: 10.1097/PAS.0000000000000900.
9
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study.皮肤免疫相关不良事件形态与全身免疫调节/免疫抑制治疗之间的关联：一项大型回顾性队列研究。
J Am Acad Dermatol. 2024 Jun;90(6):1268-1271. doi: 10.1016/j.jaad.2024.01.070. Epub 2024 Feb 9.
10
Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features.免疫检查点阻断疗法引起的苔藓样皮肤毒性：临床病理特征的详细研究
Am J Dermatopathol. 2017 Feb;39(2):121-129. doi: 10.1097/DAD.0000000000000688.
引用本文的文献
1
Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data.基于真实世界数据监测外周血数据有助于预测晚期非小细胞肺癌的免疫治疗反应。
Cancer Immunol Immunother. 2025 Feb 25;74(4):120. doi: 10.1007/s00262-025-03966-9.
2
Peptic ulcer induced by immune checkpoint inhibitors successfully treated with glucocorticoids: A report of three cases and a literature review.免疫检查点抑制剂诱发的消化性溃疡经糖皮质激素成功治疗：三例报告及文献综述
Exp Ther Med. 2024 Aug 28;28(5):410. doi: 10.3892/etm.2024.12699. eCollection 2024 Nov.
3
Atypical Presentation of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) in a Patient on Pembrolizumab: A Case Report.帕博利珠单抗治疗患者出现药物超敏反应伴嗜酸性粒细胞增多和全身症状（DRESS）的非典型表现：一例报告
Cureus. 2024 May 7;16(5):e59804. doi: 10.7759/cureus.59804. eCollection 2024 May.
4
High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer.与癌症免疫检查点阻断相关的高级别皮肤不良事件。
Front Med (Lausanne). 2022 Jun 13;9:898790. doi: 10.3389/fmed.2022.898790. eCollection 2022.
5
Contribution of the Skin-Gut Axis to Immune-Related Adverse Events with Multi-System Involvement.皮肤-肠道轴对多系统受累的免疫相关不良事件的影响。
Cancers (Basel). 2022 Jun 17;14(12):2995. doi: 10.3390/cancers14122995.
6
Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management.免疫检查点抑制剂相关性结肠炎：从发病机制到治疗管理。
Front Immunol. 2021 Dec 21;12:800879. doi: 10.3389/fimmu.2021.800879. eCollection 2021.
7
Time to dissect the autoimmune etiology of cancer antibody immunotherapy.解析癌症抗体免疫疗法的自身免疫病因学。
J Clin Invest. 2020 Jan 2;130(1):51-61. doi: 10.1172/JCI131194.
8
New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019.2019年于意大利米兰举行的第24届世界皮肤病学大会上展示的皮肤药物不良反应的新发现与进展
Drug Saf. 2020 Feb;43(2):179-187. doi: 10.1007/s40264-019-00880-9.
本文引用的文献
1
Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study.PD-1/PD-L1抑制剂治疗后皮炎的特征及其与多种肿瘤学结局的关联：一项回顾性病例对照研究。
J Am Acad Dermatol. 2018 Dec;79(6):1047-1052. doi: 10.1016/j.jaad.2018.05.035. Epub 2018 May 29.
2
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review.肿瘤和免疫检查点抑制剂相关不良反应的分类特异性模式：系统评价。
Ann Oncol. 2017 Oct 1;28(10):2377-2385. doi: 10.1093/annonc/mdx286.
3
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma.尼伏鲁单抗单药治疗的安全性概况：晚期黑色素瘤患者的汇总分析。
J Clin Oncol. 2017 Mar;35(7):785-792. doi: 10.1200/JCO.2015.66.1389. Epub 2016 Nov 14.
4
Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes.
Gastroenterology. 2002 Sep;123(3):714-8. doi: 10.1053/gast.2002.35396.
5
A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody.一种单克隆抗体检测到的人结肠、皮肤和胆管上皮细胞上的共享且独特的表位。
Gastroenterology. 1990 Feb;98(2):464-9. doi: 10.1016/0016-5085(90)90839-s.
Zotero 插件